---
ver: rpa2
title: Can Medical Vision-Language Pre-training Succeed with Purely Synthetic Data?
arxiv_id: '2410.13523'
source_url: https://arxiv.org/abs/2410.13523
tags:
- synthetic
- data
- dataset
- image
- images
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This study investigates whether medical vision-language pretraining
  (MedVLP) can succeed using purely synthetic data. The authors generate a large-scale
  synthetic dataset, SynCXR, containing 200,000 paired chest X-ray images and radiology
  reports using off-the-shelf generative models, with quality control and balanced
  entity sampling.
---

# Can Medical Vision-Language Pre-training Succeed with Purely Synthetic Data?

## Quick Facts
- arXiv ID: 2410.13523
- Source URL: https://arxiv.org/abs/2410.13523
- Authors: Che Liu; Zhongwei Wan; Haozhe Wang; Yinda Chen; Talha Qaiser; Chen Jin; Fariba Yousefi; Nikolay Burlutskiy; Rossella Arcucci
- Reference count: 40
- One-line primary result: MedVLP models pretrained exclusively on synthetic data outperform those trained on real data by 3.8% in averaged AUC on zero-shot classification tasks

## Executive Summary
This study investigates whether medical vision-language pretraining (MedVLP) can succeed using purely synthetic data. The authors generate a large-scale synthetic dataset, SynCXR, containing 200,000 paired chest X-ray images and radiology reports using off-the-shelf generative models, with quality control and balanced entity sampling. They find that MedVLP models pretrained exclusively on synthetic data outperform those trained on real data by 3.8% in averaged AUC on zero-shot classification tasks, and combining synthetic and real data yields an additional 9.07% improvement. The synthetic data also enhances performance in zero-shot grounding, fine-tuned classification, and segmentation tasks. Analysis reveals that real datasets like MIMIC-CXR suffer from low-quality images, unpaired samples, and long-tailed distributions, which degrade model performance. These findings demonstrate that well-designed synthetic data can effectively replace or complement real data for MedVLP, addressing limitations of real-world datasets.

## Method Summary
The authors generate synthetic chest X-ray images and reports using Llama3.1-70B-Instruct for report generation with balanced entity sampling, RoentGen for image generation, and quality control procedures including MLLM filtering and similarity checks. They create a dataset of 200,000 synthetic samples and train ConVIRT and GLoRIA models on both synthetic and real (MIMIC-CXR) data. The models are evaluated on zero-shot classification, grounding, fine-tuned classification, and segmentation tasks across multiple benchmarks including CheXpert, ChestXray-14, PadChest, RSNA, and SIIM.

## Key Results
- MedVLP models trained exclusively on synthetic data outperform those trained on real data by 3.8% in averaged AUC on zero-shot classification tasks
- Combining synthetic and real data leads to an additional 9.07% improvement in performance
- Synthetic data pretraining enhances performance across zero-shot grounding, fine-tuned classification, and segmentation tasks

## Why This Works (Mechanism)

### Mechanism 1
- Claim: Synthetic data with balanced entity sampling can overcome the long-tailed distribution problem in real datasets, leading to better model performance.
- Mechanism: By controlling the frequency of entities during synthetic data generation, the model is exposed to a more balanced and representative set of concepts, avoiding overfitting to frequent entities and improving generalization.
- Core assumption: The long-tailed distribution in real datasets is a primary cause of degraded MedVLP performance.
- Evidence anchors:
  - [abstract]: "Our analysis suggests MedVLP trained on well-designed synthetic data can outperform models trained on real datasets, which may be limited by low-quality samples and long-tailed distributions."
  - [section]: "As shown, all entity types exhibit a severe long-tailed distribution in the MIMIC-CXR (Johnson et al., 2019b)... which contains 154,049 unique entities, with 55,047 Abnormality, 36,365 Non-Abnormality, 23,017 Disease, 22,103 Non-Disease, and 40,517 Anatomy entities."
  - [corpus]: "Weak or missing evidence - no direct mention of long-tailed distribution mitigation in related work."
- Break condition: If the synthetic data generation process fails to maintain the balance, or if the entity sampling strategy is not effective, the long-tailed distribution problem may persist, negating the benefits of synthetic data.

### Mechanism 2
- Claim: High-quality synthetic images and reports, generated using off-the-shelf models and quality control procedures, can effectively replace real data for MedVLP.
- Mechanism: The synthetic data generation pipeline uses powerful generative models (LLMs for reports, CXR-specific T2I models for images) and applies rigorous quality control (filtering low-quality samples, ensuring entity coverage) to create a dataset that is diverse, high-quality, and representative.
- Core assumption: The quality and diversity of the synthetic data are sufficient to capture the necessary information for effective MedVLP.
- Evidence anchors:
  - [abstract]: "Our results show that MedVLP models trained exclusively on synthetic data outperform those trained on real data by 3.8% in averaged AUC on zero-shot classification."
  - [section]: "We generate 200,000 synthetic CXR images, each paired with a corresponding synthetic report, using only general-purpose, open-source models... No annotated CXR images or MedVLP models pre-trained on specific CXR image-text datasets are used in this process."
  - [corpus]: "Weak or missing evidence - no direct mention of high-quality synthetic data generation for MedVLP in related work."
- Break condition: If the generative models used are not powerful enough, or if the quality control procedures are not effective, the synthetic data may contain errors or biases that negatively impact model performance.

### Mechanism 3
- Claim: Combining synthetic and real data leads to further improvement in MedVLP performance, suggesting that synthetic data can complement real data.
- Mechanism: The synthetic data can fill in the gaps in the real data, providing additional examples and diversity that help the model learn more robust and generalizable representations.
- Core assumption: The synthetic data is complementary to the real data, and not redundant or contradictory.
- Evidence anchors:
  - [abstract]: "Moreover, using a combination of synthetic and real data leads to a further improvement of 9.07%."
  - [section]: "Additionally, MedVLP models trained on synthetic or mixed data consistently outperform those trained on real data in zero-shot grounding, as well as in fine-tuned classification and segmentation tasks."
  - [corpus]: "Weak or missing evidence - no direct mention of combining synthetic and real data for MedVLP in related work."
- Break condition: If the synthetic data is not complementary to the real data, or if it introduces additional noise or biases, the combination may not lead to further improvement, or may even degrade performance.

## Foundational Learning

- Concept: Long-tailed distribution
  - Why needed here: The long-tailed distribution in real datasets can lead to biased models that perform poorly on rare entities. Understanding this concept is crucial for designing effective synthetic data generation strategies.
  - Quick check question: What is a long-tailed distribution, and why is it a problem in machine learning?

- Concept: Entity sampling
  - Why needed here: Entity sampling is a key technique used to control the frequency of entities in the synthetic data, ensuring a balanced and representative dataset. Understanding this concept is essential for implementing the synthetic data generation pipeline.
  - Quick check question: What is entity sampling, and how can it be used to address the long-tailed distribution problem?

- Concept: Quality control in synthetic data generation
  - Why needed here: Quality control is essential to ensure that the synthetic data is accurate, diverse, and representative. Understanding the various quality control procedures is crucial for implementing an effective synthetic data generation pipeline.
  - Quick check question: What are some common quality control procedures used in synthetic data generation, and why are they important?

## Architecture Onboarding

- Component map: LLMs for report generation -> CXR-specific T2I models for image generation -> Quality control (MLLM filtering, similarity checks) -> MedVLP model training (ConVIRT, GLoRIA) -> Evaluation on downstream tasks

- Critical path: Generate synthetic reports and images -> Apply quality control procedures -> Train MedVLP models on synthetic data -> Evaluate model performance on downstream tasks

- Design tradeoffs: Using general-purpose models vs. domain-specific models for data generation, balancing the diversity and quality of synthetic data, tradeoff between the size and diversity of the synthetic dataset

- Failure signatures: Poor performance on downstream tasks, biased or inaccurate synthetic data, long-tailed distribution persisting in the synthetic data

- First 3 experiments:
  1. Train a MedVLP model on synthetic data generated using a general-purpose LLM and evaluate its performance on zero-shot classification.
  2. Apply quality control procedures to the synthetic data and retrain the MedVLP model, evaluating its performance again.
  3. Combine synthetic and real data and train a MedVLP model, evaluating its performance on a range of downstream tasks.

## Open Questions the Paper Calls Out

### Open Question 1
- Question: What is the optimal balance between synthetic and real data for MedVLP training to maximize performance across different downstream tasks?
- Basis in paper: [explicit] The paper shows that combining synthetic and real data improves performance over using either alone, but doesn't explore the optimal mixing ratio
- Why unresolved: The study only uses a 50/50 mix of synthetic and real data without exploring different ratios or task-specific optimal combinations
- What evidence would resolve it: Systematic experiments varying the synthetic:real data ratio (e.g., 25:75, 50:50, 75:25) across different downstream tasks and analyzing performance curves

### Open Question 2
- Question: How do different types of synthetic data generation errors (e.g., anatomical inaccuracies, clinical inconsistencies) specifically impact MedVLP model performance?
- Basis in paper: [inferred] The paper mentions quality control and filtering procedures but doesn't analyze how different types of errors affect model performance
- Why unresolved: The study focuses on overall performance improvements but doesn't decompose the impact of specific types of synthetic data errors
- What evidence would resolve it: Controlled experiments introducing specific types of errors in synthetic data and measuring their differential impact on model performance

### Open Question 3
- Question: What are the long-term generalization capabilities of MedVLP models trained exclusively on synthetic data when deployed on real-world medical datasets?
- Basis in paper: [explicit] The paper evaluates performance on existing benchmark datasets but doesn't address deployment in clinical settings
- Why unresolved: The study is limited to controlled experimental conditions and doesn't examine real-world deployment scenarios
- What evidence would resolve it: Longitudinal studies tracking model performance across different clinical settings, patient populations, and imaging protocols

### Open Question 4
- Question: How does the entity sampling strategy in synthetic report generation affect the model's ability to handle rare diseases and complex clinical scenarios?
- Basis in paper: [explicit] The paper uses balanced entity sampling but doesn't explore its impact on rare disease detection or complex clinical patterns
- Why unresolved: The study focuses on overall performance metrics but doesn't specifically analyze performance on rare diseases or complex clinical cases
- What evidence would resolve it: Detailed analysis of model performance on rare diseases and complex clinical scenarios under different entity sampling strategies

## Limitations

- The study focuses exclusively on chest X-rays, limiting generalizability to other medical imaging modalities
- Quality control pipeline implementation details and threshold values are not fully specified
- Synthetic data generation uses off-the-shelf models without fine-tuning on medical data, potentially impacting long-term scalability and domain-specific accuracy

## Confidence

- **High confidence**: The finding that synthetic data outperforms real data on zero-shot classification tasks (3.8% AUC improvement) is well-supported by the experimental results and analysis of real dataset limitations
- **Medium confidence**: The claim that combining synthetic and real data yields an additional 9.07% improvement is supported but may depend on specific dataset characteristics and quality control parameters
- **Medium confidence**: The assertion that synthetic data can effectively replace real data for MedVLP is supported by the experimental results but requires further validation across diverse medical imaging tasks and modalities

## Next Checks

1. **Cross-modality validation**: Replicate the study using different medical imaging modalities (CT, MRI, pathology) to assess generalizability beyond chest X-rays.

2. **Quality control parameter sensitivity**: Systematically vary the MLLM filtering thresholds and RAD-DINO similarity cutoffs to determine their impact on model performance and identify optimal configurations.

3. **Long-term performance monitoring**: Track model performance over time as synthetic data generation improves, assessing whether initial advantages persist or grow with advancing generative model capabilities.